ClinicalTrials.gg
RecruitingNCT06779812AURDOUpdated Sep 10, 2026

Impact of Auriculotherapy on Postoperative Pain in Patients Undergoing Surgery for SCC

An interventional study of Carpal Tunnel Surgery and real auricolothery in Pain After Carpal Tunnel Surgery, sponsored by Clinique Bizet. Recruiting at 2 sites in France. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Clinique Bizet · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 482 studies in Pain with a site in France — 75 open to participants now, 79 under way, 8 of them phase 3. Pain · France.

Planned enrollment
245th of 369
50 · median 80
Started
2025
with 24 others
No phase
225 of 482
50 open now
Primary completion
2026-12
later than 31 of 78 live
Registered
437th of 482
by date

Among the 482 studies in Pain with a site in France, this one is the 245th largest by planned enrollment of the 369 interventional ones that give a count, is one of 25 that started in 2025, is one of 225 with no phase, reaches primary completion later than 31 of the 78 other live ones, and was the 437th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

75 of the 482 studies in Pain with a site in France are open now. Recruiting first, the newest first:

70 more — sign in →

All 75 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 20 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 482 studies in Pain with a site in France, or all of them as a file.
02

Study summary

Auriculotherapy shows promising potential for pain management in patients with carpal tunnel syndrome (CTS). Studies have demonstrated encouraging results in pain reduction and improvement in quality of life. However, further research is required to strengthen these findings and fully integrate auriculotherapy into standard treatment protocols for CTS.

this prospective, double-blind comparative study aims to evaluate the effectiveness of auricular acupuncture in managing postoperative pain following outpatient carpal tunnel surgery

03

Conditions studied

  • Pain After Carpal Tunnel Surgery

Browse trials for

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subjects aged over 20 years
  • Patients with carpal tunnel syndrome scheduled for endoscopic surgery
  • Patients who have never undergone auriculotherapy sessions before
  • No participation in another clinical study

Exclusion criteria

Exclusion Criteria:

  • Patients under 20 years of age
  • Unable to undergo medical follow-up for the study
  • Legally protected adult subjects, under guardianship or curatorship
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Group A

    Real auriculotherapy + standard medical care

    Procedure: Carpal Tunnel Surgery · Other: real auricolothery

  • Sham comparator
    Group B

    Sham auriculotherapy + standard medical care

    Procedure: Carpal Tunnel Surgery · Other: sham auriculotherapy

Interventions

  • ProcedureCarpal Tunnel Surgery

    Carpal tunnel surgery is performed endoscopically, using smaller incisions. Endoscopic surgery is a minimally invasive method that allows for faster and less painful recovery

  • Otherreal auricolothery

    3 days before the intervention, patients will have an auriculotherapy session with an experimental group

  • Othersham auriculotherapy

    3 days before the intervention, patients will have an auriculotherapy session with an sham group

06

What researchers measure

Primary outcomes

  1. Evaluation of Postoperative Pain After Carpal Tunnel Surgery From Day 1 to Day 3, Based on Real or Sham Auriculotherapy Sessions

    Visual analog scale

    Time frame: day1 to day 3

Secondary outcomes

  1. Evaluation of the Effects of Real or Sham Auriculotherapy Sessions on Analgesic Consumption

    Analgesic Consumption

    Time frame: Follow-up Logbook from Day 1 to Day 3

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Dec 2026, 20 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 20 months is above that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 8, 2025
First posted
Jan 17, 2025
StartActual
Apr 11, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Sep 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06779812
Lead sponsor
Clinique Bizet
Responsible party
Sponsor
First posted
Jan 17, 2025
Start date
Apr 11, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Sep 10, 2026

Study contacts

bouchra BENKESSOU, PM
Contact
b.benkessou@hexagone-sante-paris.fr
0033764486016
Christian COUTURIER, Dr
Contact

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion